Masked hypertension a phenomenon of measurement

Hypertension

Volumn 65, Issue 1, 2015, Pages 16-20

  Franklin, Stanley S ^a   O'Brien, Eoin ^b   Thijs, Lutgarde ^c   Asayama, Kei ^c,d   Staessen, Jan A ^c,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e TOHOKU UNIVERSITY   (Japan)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DISEASE COURSE; HUMAN; MASKED HYPERTENSION; META ANALYSIS (TOPIC); PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; BLOOD PRESSURE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; MASKED HYPERTENSION;

EID: 84919398391     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.114.04522     Document Type: Review

References (44)

1. OBrien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731-1768.
2. Owens P, Atkins N, OBrien E. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Hypertension. 1999;34:267-272.
3. Kikuya M, Hansen TW, Thijs L, et al. diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation. 2007;115:2125-2152.
4. Mancia G, Fagard R, Narkiewicz K, et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESH). J Hypertens. 2013;31:1281-1357.
5. Niiranen TJ, Asayama K, Thijs L, Johansson GK, Ohkubo T, Kikuya M, boggia J, Hozawa A, Sandoya E, Stergiou GS, Tsuji I, Jula AM, Imai Y, Staessen JA. Outcome-driven thresholds for home blood pressure measurement: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2013;61:27-34.
6. Brguljan-Hitij J, Thijs L, Li Y, et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcome Investigators. Risk stratification by ambulatory blood pressure monitoring across JNC classes of conventional blood pressure. Am J Hypertens. 2014;27:956-965.
7. Chobanian AV, Bakis GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1251.
8. Cacciolati C, Tzourio C, Hanon O. Blood pressure variability in elderly persons with white-coat and masked hypertension compared to those with normotension and sustained hypertension. Am J Hypertens. 2013;26:367-372.
9. Tabara Y, Okada Y, Uetani E, Nagai T, Igase M, Kido T, Ochi N, Ohara M, Takita R, Kohara K, Miki T. Postprandial hypotension as a risk marker for asymptomatic lacunar infarction. J Hypertens. 2014;32:1084-1090.
10. Trudel X, Brisson C, Milot A. Job strain and masked hypertension. Psychosom Med. 2010;72:786-793.
11. Landsbergis PA, Dobson M, Koutsouras G, Schnall P. Job strain and ambulatory blood pressure: a meta-analysis and systematic review. Am J Public Health. 2013;103:e61-e71.
12. Seki M, Inoue R, Ohkubo T, Kikuya M, Hara A, Metoki H, Hirose T, Tsubota-Utsugi M, Asayama K, Kanno A, Obara T, Hoshi H, Totsune K, Satoh H, Imai Y. Association of environmental tobacco smoke exposure with elevated home blood pressure in Japanese women: the Ohasama study. J Hypertens. 2010;28:1814-1820.
13. Ohira T, Tanigawa T, Tabata M, Imano H, Kitamura A, Kiyama M, Sato S, Okamura T, Cui R, Koike KA, Shimamoto T, Iso H. Effects of habitual alcohol intake on ambulatory blood pressure, heart rate, and its variability among Japanese men. Hypertension. 2009;53:13-19.
14. Schultz MG, Hare JL, Marwick TH, Stowasser M, Sharman JE. Masked hypertension is unmasked by low-intensity exercise blood pressure. Blood Press. 2011;20:284-289.
15. Sharman JE, Hare JL, Thomas S, Davies JE, Leano R, Jenkins C, Marwick TH. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens. 2011;24:898-903.
16. Hanninen MR, Niiranen TJ, Puukka PJ, Jula AM. Metabolic risk factors and masked hypertension in the general population: the Finn-Home study. J Hum Hypertens. 2014;28:1-6.
17. Franklin SS, Thijs L, Li Y, et al; International Database on Ambulatory blood pressure in Relation to Cardiovascular Outcomes Investigators. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension. 2013;61:964-971.
18. Bangash F, Agarwal R. Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol. 2009;4:656-664.
19. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Sleep-time blood pressure and masked hypertension. Am J Hypertens. 2012;25:297-305.
20. Li Y, Wang JG. Isolated nocturnal hypertension: a disease masked in the dark. Hypertension. 2013;61:278-283.
21. Fan HQ, Li Y, Thijs L, et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036-2045.
22. Del la Sierra A, Gorostidi M, Benegas JR, Segura J, del la Cruz JJ, Ruilope LM. Nocturnal Hypertension or nondipping: which is better associated with the cardiovascular risk profile? Am J Hypertens. 2013;27:680-687.
23. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R. Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens. 2010;23:1190-1197.
24. Pickering TG, Gerin W, Schwartz JE, Spruill TM, Davidson KW. Franz Volhard lecture: should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens. 2008;26:2259-2267.
25. Trudel X, Milot A, Brisson C. Persistence and progression of masked hypertension: a 5-year prospective study. Int J Hypertens. 2013;2013:836387.
26. Oe Y, Shimbo D, Ishikawa J, Okajima K, Hasegawa T, Diaz KM, Muntner P, Homma S, Schwartz JE. Alterations in diastolic function in masked hypertension: findings from the masked hypertension study. Am J Hypertens. 2013;26:808-815.
27. Hänninen MR, Niiranen TJ, Puukka PJ, Kesäniemi YA, Kähönen M, Jula AM. Target organ damage and masked hypertension in the general population: the Finn-Home study. J Hypertens. 2013;31:1136-1143.
28. Franklin SS, Thijs L, Hansen TW, et al; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564-571.
29. Staessen JA, Thijs L, Ohkubo T, Kikuya M, Richart T, Boggia J, Adiyaman A, Dechering DG, Kuznetsova T, Thien T, de Leeuw P, Imai Y, Obrien E, Parati G. Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit. 2008;13:352-365.
30. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004;22:435-445.
31. Schmieder RE, Schmidt ST, Riemer T, Dechend R, Hagedorn I, Senges J, Messerli FH, Zeymer U. Disproportional decrease in office blood pressure compared with 24-hour ambulatory blood pressure with antihypertensive treatment: dependency on pretreatment blood pressure levels. Hypertension. 2014;64:1067-1072.
32. Parati G, Ulian L, Sampieri L, Palatini P, villanl A, Vanasia A, Mancia G, on behalf of the Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation (SAMPLE) Study Group. Attenuation of the white-coat effect by antihypertensive treatment and regression of target organ damage. Hypertension. 2000;35:614-620.
33. Agarwal R, Weir MR. Treated hypertension and the white coat phenomenon: Office readings are inadequate measures of efficacy. J Am Soc Hypertens. 2013;7:236-243.
34. Myers MG, Godwin M, Dawes M Kiss A, Tobe SW, Kaczorowski J. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomized parallel design controlled trial. BMJ. 2011;342:286-294.
35. Hänninen MR, Niiranen TJ, Puukka PJ, Mattila AK, Jula AM. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens. 2011;29:1880-1888.
36. Asayama K, Thijs L, Brguljan-Hitij J, et al. Risk stratification by selfmeasured home blood pressure across categories of conventional blood pressure: a Participant-level meta-analysis. PLoS Med. 2014;11:1-16.
37. Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, Boggia J, Johansson JK, Ohkubo T, Tsuji I, Jula AM, Imai Y, Staessen JA; International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome. Hypertension. 2014;63:675-682.
38. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, Heneghan C, Roberts N, McManus RJ. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.
39. Kario K. Diagnosis of true uncontrolled hypertension using both home and ambulatory blood pressure monitoring. J Hum Hypertens. 2014;28:176-179.
40. Niiranen TJ, Maki J, Puukka P, Karanko H, Jula AM. Office, Home, and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension. 2014;64:281-286.
41. del la Sierra A, Benegas JR, Segura J, Gorosidi M. Ruilope LM. Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: the CARDIORISC E STUDY. J Hypertens. 2012;39:713-719.
42. Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura JS, Martell N, Garcia-Puig J, Deanfield J, Williums B. High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014. doi: 10.1093/eurheartj/ehu016. http://eurheartj.oxfordjournals.org/content/early/2014/02/03/eurheartj.ehu016. full. Accessed February 3, 2014.
43. Banegas JR, Messerli F H, Waeber B, Rodriguez-Aralejo F, del la Sierra A, Segura J, Martell N, Garcia-Puig J, Deanfield J, Williams B. Discrepancies between office and ambulatory blood pressure: clinical implications. Am J Med. 2009;122:1136-1141.
44. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboli P, Conte G, Gabbai FB, De Nicola L. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090-1098.